Overview

An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density

Status:
Completed

Trial end date:
2012-08-02

Target enrollment:

Participant gender:

Summary

An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women with Low Bone Mineral Density

Phase:

Phase 3

Details

Lead Sponsor:

Amgen

Treatments:

Denosumab